TY - JOUR
T1 - Knowledge, Attitudes, and Practice of Hospital Pharmacists Regarding Pharmacovigilance and Adverse Drug Reaction Reporting in Japan
AU - Kobayashi, Tomonori
AU - Noda, Aoi
AU - Obara, Taku
AU - Tsuchiya, Masami
AU - Akasaka, Kazutoshi
AU - Yoshida, Makiko
AU - Matsuura, Masaki
AU - Sato, Mayumi
AU - Murai, Yuriko
AU - Yamaguchi, Hiroaki
AU - Tsuchiya, Fumito
AU - Kihira, Kenji
AU - Mano, Nariyasu
N1 - Funding Information:
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was partially supported by the Research on Regulatory Harmonization and Evaluation of Pharmaceuticals, Medical Devices, Regenerative and Cellular Therapy Products, Gene Therapy Products, and Cosmetics from the Japan Agency for Medical Research and Development, AMED.
Funding Information:
The authors thank the Japanese Society of Hospital Pharmacists. The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was partially supported by the Research on Regulatory Harmonization and Evaluation of Pharmaceuticals, Medical Devices, Regenerative and Cellular Therapy Products, Gene Therapy Products, and Cosmetics from the Japan Agency for Medical Research and Development, AMED.
Publisher Copyright:
© The Author(s) 2019.
PY - 2021/2
Y1 - 2021/2
N2 - Background: The importance of pharmacovigilance in Japan is gradually being recognized. However, Japanese pharmacists’ knowledge of and perspectives on pharmacovigilance have been examined only in some areas of Japan. Objective: The objective of this study was to clarify the knowledge, attitudes, and practice regarding pharmacovigilance and adverse drug reaction (ADR) reporting among hospital pharmacists in Japan. Setting: A questionnaire survey among Japanese hospital pharmacists. Method: The questionnaire was distributed to 48 028 pharmacists during a 3-month period between January and March 2017. Main Outcome Measure: The prevalence of hospital pharmacists who understood pharmacovigilance and the ADR reporting system. Results: Of the respondents (response rate; 9.9% = 4760/48 028), 21.9% were <30 years of age, 27.3% were ≥50 years of age, and 46.7% were women. In response to the question “Have you ever heard of the term ‘pharmacovigilance’?,” 12.4%, 33.8%, and 47.4% answered “I understand what it is,” “I have heard of it, but I do not understand what it is,” and “I do not know what it is,” respectively. Pharmacists who understood the term “pharmacovigilance” were also more frequently acquainted with its associated terms and actions. And, 69.7% of respondents wished to acquire more information on pharmacovigilance and 50.9% did not have a personal history of ADR reporting. The most common reason for ADR nonreporting was “It was a well-known adverse drug reaction” (44.5%). Conclusions: Our results suggest that more aggressive promotion of pharmacovigilance and of the ADR reporting system among Japanese pharmacists is needed.
AB - Background: The importance of pharmacovigilance in Japan is gradually being recognized. However, Japanese pharmacists’ knowledge of and perspectives on pharmacovigilance have been examined only in some areas of Japan. Objective: The objective of this study was to clarify the knowledge, attitudes, and practice regarding pharmacovigilance and adverse drug reaction (ADR) reporting among hospital pharmacists in Japan. Setting: A questionnaire survey among Japanese hospital pharmacists. Method: The questionnaire was distributed to 48 028 pharmacists during a 3-month period between January and March 2017. Main Outcome Measure: The prevalence of hospital pharmacists who understood pharmacovigilance and the ADR reporting system. Results: Of the respondents (response rate; 9.9% = 4760/48 028), 21.9% were <30 years of age, 27.3% were ≥50 years of age, and 46.7% were women. In response to the question “Have you ever heard of the term ‘pharmacovigilance’?,” 12.4%, 33.8%, and 47.4% answered “I understand what it is,” “I have heard of it, but I do not understand what it is,” and “I do not know what it is,” respectively. Pharmacists who understood the term “pharmacovigilance” were also more frequently acquainted with its associated terms and actions. And, 69.7% of respondents wished to acquire more information on pharmacovigilance and 50.9% did not have a personal history of ADR reporting. The most common reason for ADR nonreporting was “It was a well-known adverse drug reaction” (44.5%). Conclusions: Our results suggest that more aggressive promotion of pharmacovigilance and of the ADR reporting system among Japanese pharmacists is needed.
KW - adverse drug reactions
KW - adverse drug reactions reporting/monitoring
KW - education
KW - pharmacists
UR - http://www.scopus.com/inward/record.url?scp=85068833827&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85068833827&partnerID=8YFLogxK
U2 - 10.1177/0018578719851455
DO - 10.1177/0018578719851455
M3 - Article
AN - SCOPUS:85068833827
SN - 0018-5787
VL - 56
SP - 7
EP - 16
JO - Hospital Pharmacy
JF - Hospital Pharmacy
IS - 1
ER -